A Pilot Safety and Pharmacokinetic Study of MB-102 Versus Iohexol and the Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types

Trial Profile

A Pilot Safety and Pharmacokinetic Study of MB-102 Versus Iohexol and the Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Sep 2017

At a glance

  • Drugs APC 2 (Primary) ; Iohexol
  • Indications Acute kidney injury
  • Focus Adverse reactions
  • Sponsors MediBeacon
  • Most Recent Events

    • 02 Mar 2017 Status changed from recruiting to completed, according to a MediBeacon media release.
    • 20 Feb 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jul 2017.
    • 07 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top